Literature DB >> 17255356

The role of PKC and PDK1 in monocyte lineage specification by Ras.

Lorna Pearn1, Janet Fisher, Alan K Burnett, Richard L Darley.   

Abstract

Although hyperactivation of Ras is a common feature of myeloid malignancy, its role in subverting hematopoiesis is unclear. We have examined the influence of Ras on normal human uncommitted myeloid subsets and show that expression of this oncogene strongly favors monocyte lineage selection in bipotential granulocyte/macrophage progenitors while inhibiting colony formation in other uncommitted subsets. Ras also promoted monocytic differentiation but not the proliferation of these cells. The mechanism through which Ras drives monocyte lineage selection was dependent on PKC activity and Ras was found to promote the expression, membrane translocation, and phosphorylation of conventional and novel PKC isoforms. We further show that Ras promoted the expression of the AGC kinase master regulator, PDK1, which maintains the stability and activity of PKC isoforms. Consistent with this, overexpression of PDK1 itself promoted monocyte colony formation and translocation of PKC. Overexpression of PDK1 was found to be a common feature of acute myeloid leukemia (45% of patients) and was closely associated with hyperphosphorylation of PKC. These data demonstrate that Ras is able to promote monocyte lineage selection via PKC and show for the first time the involvement of the kinase master regulator, PDK1, in both lineage specification and in human leukemia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17255356     DOI: 10.1182/blood-2006-09-047217

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

Review 1.  Emerging role of the KRAS-PDK1 axis in pancreatic cancer.

Authors:  Riccardo Ferro; Marco Falasca
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  Calorie restriction prevents the development of insulin resistance and impaired lipid metabolism in gestational diabetes offspring.

Authors:  Tao Li; Keyang Chen; Gang Liu; Li-Ping Huang; Long Chen; Qiu-Wei Wang; Chuan-Lai Hu; Li-Juan Hou
Journal:  Pediatr Res       Date:  2016-12-26       Impact factor: 3.756

Review 3.  Regulation of monocyte differentiation by specific signaling modules and associated transcription factor networks.

Authors:  René Huber; Daniel Pietsch; Johannes Günther; Bastian Welz; Nico Vogt; Korbinian Brand
Journal:  Cell Mol Life Sci       Date:  2013-03-24       Impact factor: 9.261

4.  The PDK1 master kinase is over-expressed in acute myeloid leukemia and promotes PKC-mediated survival of leukemic blasts.

Authors:  Joanna Zabkiewicz; Lorna Pearn; Robert K Hills; Rhys G Morgan; Alex Tonks; Alan K Burnett; Richard L Darley
Journal:  Haematologica       Date:  2013-12-13       Impact factor: 9.941

5.  Expression of 3-phosphoinositide-dependent protein kinase 1 in colorectal cancer as a potential therapeutic target.

Authors:  Zhenglei Xu; Bihong Liao; Ru Zhang; Jun Yao; Ruiyue Shi; Lisheng Wang
Journal:  Med Oncol       Date:  2015-06-09       Impact factor: 3.064

Review 6.  Targeting mTOR signaling pathways and related negative feedback loops for the treatment of acute myeloid leukemia.

Authors:  Benedito A Carneiro; Jason B Kaplan; Jessica K Altman; Francis J Giles; Leonidas C Platanias
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

7.  Loss of Dnmt3b accelerates MLL-AF9 leukemia progression.

Authors:  Y Zheng; H Zhang; Y Wang; X Li; P Lu; F Dong; Y Pang; S Ma; H Cheng; S Hao; F Tang; W Yuan; X Zhang; T Cheng
Journal:  Leukemia       Date:  2016-05-02       Impact factor: 11.528

Review 8.  C/EBPalpha induces PU.1 and interacts with AP-1 and NF-kappaB to regulate myeloid development.

Authors:  Alan D Friedman
Journal:  Blood Cells Mol Dis       Date:  2007-07-31       Impact factor: 3.039

Review 9.  Vitamin D3-driven signals for myeloid cell differentiation--implications for differentiation therapy.

Authors:  Philip J Hughes; Ewa Marcinkowska; Elzbieta Gocek; George P Studzinski; Geoffrey Brown
Journal:  Leuk Res       Date:  2009-10-06       Impact factor: 3.156

Review 10.  The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients.

Authors:  Alberto M Martelli; Camilla Evangelisti; Francesca Chiarini; James A McCubrey
Journal:  Oncotarget       Date:  2010-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.